Capital

302, 2022

Avicanna Provides Q4-2021 Results Fiscal 2022 Outlook

TORONTO - Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, ...

Go to Top